Organogenesis Holdings Inc. (ORGO) Financial Metrics
This dashboard provides comprehensive financial metrics and analysis to help evaluate Organogenesis Holdings Inc.'s investment potential. View key valuation ratios, profitability metrics, growth indicators, and historical trends to make informed investment decisions.
Financial Metrics Score
Valuation Metrics
Sector benchmarks: Industrials
P/E Ratio
32.38
Weak
WeakModerateStrong
P/B Ratio
1.51
Strong
WeakModerateStrong
Earnings Yield
5.64%
Strong
WeakModerateStrong
Profitability Health
2025Return on Equity
8.53%
Weak
WeakModerateStrong
Operating Margin
9.92%
Weak
WeakModerateStrong
Net Profit Margin
6.58%
Weak
WeakModerateStrong
Growth Indicators
2025Revenue Growth
16.80%
Strong
WeakModerateStrong
Net Income Growth
4201.05%
Strong
WeakModerateStrong
EPS Growth
2353.52%
Strong
WeakModerateStrong
Efficiency & Liquidity
2025Current Ratio
3.62
Strong
WeakModerateStrong
Quick Ratio
3.32
Strong
WeakModerateStrong
Asset Turnover
0.94x
Moderate
WeakModerateStrong
Inventory Turnover
4.64x
Moderate
WeakModerateStrong
Cash Flow & Resilience
Core fortress metrics for cash-rich balance sheets in high-inflation / tech-volatility regimes
Free Cash Flow Yield
-3.73%
Weak
WeakModerateStrong
EV / Free Cash Flow
-28.44x
Strong
WeakModerateStrong
Net Debt / EBITDA
0.53x
Strong
WeakModerateStrong
Interest Burden (EBT / EBIT)
0.841
Weak
WeakModerateStrong
Return on Invested Capital
8.52%
Weak
WeakModerateStrong
Cash Conversion Cycle
134.81 days
Weak
WeakModerateStrong
Fortress screener guardrails
1/4 passing
- FCF Yield > 3%
- Net Debt / EBITDA < 1.5x
- ROIC > 20%
- Cash Conversion Cycle < 0 days
Financial Statements
Want to see the complete financial picture? View detailed financial statements including income statements, balance sheets, and cash flow statements for ORGO.
View Financial Statements